Update on Pharmstandard buy-back program.

17.07.2013

HTML-редакторПеренос слов

Moscow, July 17, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») announces that pursuant to the Company’s buyback program, announced on February 15, 2013 (further the «Program»), 15 009 162 GDRs and 140 000 ordinary shares were purchased on the open market as of July 16, 2013. All purchases of GDRs were made by an independent broker Citigroup Global Markets Limited for the account of Pharmstandard-Leksredstva OJSC, an indirect wholly owned subsidiary of the Company.

Therefore, since the start of Pharmstandard’s buyback program the following securities have been purchased:

Date

Type

Amount (shares)

Price per share

Amount

USD

RUR

USD

RUR

22/04/13

GDR

220 000

20,4659

643,87

4 502 498,00

141 650 838,33

26/04/13

GDR

3 056 305

20,4000

638,86

62 348 622,00

1 952 565 560,31

20/06/13

ORDS

140 000

65,4082

2 150,00

9 157 148,00

301 000 000,00

26/06/13

GDR

1 718 574

20,3500

665,73

34 972 980,90

1 144 106 097,16

26/06/13

GDR

115 421

20,5500

672,27

2 371 901,55

77 594 387,31

09/07/13

GDR

364 000

16,8500

561,46

6 133 400,00

204 371 021,40

10/07/13

GDR

2 833 075

15,8500

528,14

44 904 238,75

1 496 254 139,39

11/07/13

GDR

3 000 000

11,9000

387,78

35 700 000,00

1 163 345 190,00

12/07/13

GDR

1 100 000

10,9500

356,82

12 045 000,00

392 506 801,50

15/07/13

GDR

410 000

12,9000

421,09

5 289 000,00

172 648 298,10

16/07/13

GDR

2 191 787

13,6000

443,66

29 808 303,20

972 406 466,99

Total :

 

15 149 162

 

 

247 233 092,40

8 018 448 800,49

The last buy-back took place on July 16: 2 191 787 GDRs at the price of 13,60 USD per GDR.

The Program was approved in respect of ordinary shares of Pharmstandard OJSC and/or Global Depositary Receipts representing Shares (each Share representing 4 GDRs) in the aggregate amount of up to RUR8 billion. Duration of program: December 31, 2013.

The total sum of securities purchased as of July 16, 2013 constitutes RUR 8 018 448 800,49, hence, the Programs may be considered as completed.

New shareholder structure is as follows:

Augment Investments Limited – 54,3185% (ordinary shares and GDRs)

LSE – 17,64% (GDRs)

RTS/MICEX – 9,31% (ordinary shares)

Pharmstandard-Leksredstva OJSC – 18,7392% % (ordinary shares and GDRs) 

Regards,
Irina Bakhturina
Investor Relations
Pharmstandard OJSC
Tel.   (495) 970-0030 ext.2824
Fax   (495) 970-0032
www.pharmstd.ru

ИзменитьОтмена


Back Print out